Added to YB: 2024-03-22
Pitch date: 2024-01-23
DXCM [bullish]
DexCom, Inc.
-47.73%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
Market Cap
$23.5B
Pitch Price
$128.10
Price Target
N/A
Dividend
N/A
EV/EBITDA
21.49
P/E
33.52
EV/Sales
5.04
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
Next Century Growth Investors SMID Cap Growth Strategy New Portfolio holding: DexCom, Inc.
DXCM: Leader in CGM for diabetes, taking share from fingersticks. Improved accuracy, functionality, indications, insulin pump integration, reimbursement & geographic expansion driving strong revenue growth & rising profitability. Set to continue delivering in the future.
Read full article (1 min)